# Novo Nordisk (Switzerland)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/novo-nordisk-switzerland/

## Facts

| Field | Value |
| --- | --- |
| Citations | 26,882 |
| City | Zurich |
| Country | CH |
| Description | Novo Nordisk (Switzerland) is a research organisation in Zurich, CH. OpenAlex records 591 works and 26,882 citations for it. 182 researchers list it as their most recent affiliation. |
| Homepage | http://www.novonordisk.com/ |
| OpenAlex ID | https://openalex.org/I4210107308 |
| Researchers | 182 |
| ROR ID | https://ror.org/01p1t0k52 |
| Type | company |
| Works | 591 |

## University top topics

Showing 8 of 25.

- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Growth Hormone and Insulin-like Growth Factors](https://scholariq.org/topics/growth-hormone-and-insulin-like-growth-factors/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.